VanEck Associates’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Sell
3,758
-8,739
-70% -$2.49M ﹤0.01% 1081
2026
Q1
$2.17M Sell
12,497
-8,828
-41% -$1.81M ﹤0.01% 973
2025
Q4
$5.46M Buy
21,325
+9,312
+78% +$2.44M ﹤0.01% 755
2025
Q3
$3.13M Buy
12,013
+8,994
+298% +$2.37M ﹤0.01% 904
2025
Q2
$738K Sell
3,019
-544
-15% -$136K ﹤0.01% 1104
2025
Q1
$943K Buy
3,563
+197
+6% +$53.3K ﹤0.01% 1047
2024
Q4
$854K Buy
3,366
+2,027
+151% +$544K ﹤0.01% 1061
2024
Q3
$346K Buy
+1,339
New +$477K ﹤0.01% 1128
2024
Q1
Sell
-1,512
Closed -$692K 1391
2023
Q4
$692K Sell
1,512
-256
-14% -$126K ﹤0.01% 1009
2023
Q3
$860K Buy
+1,768
New +$831K ﹤0.01% 932
2021
Q3
Sell
-1,630
Closed -$722K 1307
2021
Q2
$722K Buy
1,630
+64
+4% +$28K ﹤0.01% 856
2021
Q1
$657K Buy
1,566
+298
+24% +$119K ﹤0.01% 809
2020
Q4
$520K Buy
1,268
+846
+200% +$352K ﹤0.01% 770
2020
Q3
$175K Buy
+422
New +$170K ﹤0.01% 833

Other funds holding HUM

VanEck Associates's HUM Position: Q2 2026 in Review

VanEck Associates reduced its Humana (HUM) stake by 70% in Q2 2026, selling an estimated $2.49M and leaving 3,758 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1081.

VanEck Associates first reported a position in HUM in Q3 2020 and has held it in 14 quarters since. The position peaked at $5.46M in Q4 2025. 925 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • VanEck Associates held 3,758 shares of Humana worth $1.49M as of Q2 2026.
  • VanEck Associates sold 8,739 Humana shares in Q2 2026, an estimated $2.49M.
  • Humana made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1081 holding.
  • VanEck Associates first reported a position in Humana in Q3 2020 and has held it in 14 quarters since.
  • VanEck Associates's Humana position peaked at $5.46M in Q4 2025.
  • 925 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.